Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedReplaced Napoli, Italy, 80138 with Naples, Italy, 80138 to standardize the study site location naming.SummaryDifference0.0%

- Check23 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0; no substantive changes to study details were observed.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check59 days agoChange DetectedFooter now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No substantive changes to the study details or page layout were observed.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded a glossary display option and standardized the QC labeling to 'Last Update Submitted that Met QC Criteria'. Capitalization for 'No FEAR Act Data' was applied and the page revision updated to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.